BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 1925814)

  • 1. Reversal of structural changes in hypertensive arteries--a major prospect for the future.
    Rosendorff C
    S Afr Med J; 1991 Sep; Suppl():4-6. PubMed ID: 1925814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular effects of perindopril: from experimental to clinical investigation.
    Scalbert E; Levy B; Desche P; Devissaguet M; Safar ME
    J Cardiovasc Pharmacol; 1991; 18 Suppl 7():S25-32. PubMed ID: 1725197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Function and structure of the vascular wall in experimental arterial hypertension. Effect of treatment].
    Michel JB; Tedgui A; Salzmann JL; Belmain J; Lévy B
    Nephrologie; 1989; 10(2):55-7. PubMed ID: 2677815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The blood vessel as a target organ in hypertension: protective effect of perindopril.
    Plante GE
    Can J Cardiol; 1994 Nov; 10 Suppl D():25D-29D. PubMed ID: 7954036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of perindopril on vascular smooth muscle polyploidy in stroke-prone spontaneously hypertensive rats.
    Devlin AM; Gordon JF; Davidson AO; Clark JS; Hamilton CA; Morton JJ; Campbell AM; Reid JL; Dominiczak AF
    J Hypertens; 1995 Feb; 13(2):211-8. PubMed ID: 7615951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular hypertrophy in hypertension: role of the renin-angiotensin system.
    Rosendorff C
    Mt Sinai J Med; 1998 Mar; 65(2):108-17. PubMed ID: 9520514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin converting enzyme (ACE) inhibitors in experimental hypertension: influence on heart and arteries.
    Levy BI; Salzmann JL; Devissaguet M; Safar ME; Michel JB
    Basic Res Cardiol; 1991; 86 Suppl 1():43-53. PubMed ID: 1827984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin converting enzyme inhibition and vascular hypertrophy in hypertension.
    Gibbons GH; Dzau VJ
    Cardiovasc Drugs Ther; 1990 Feb; 4(1):237-42. PubMed ID: 2285616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Structural and functional changes of the microcirculation in hypertension: influence of pharmacological therapy].
    Agabiti-Rosei E
    Drugs; 2003; 63 Spec No 1():19-29. PubMed ID: 12708883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Regression of hypertensive cardiovascular changes during treatment with antihypertensive ddrugs].
    Schroeder AP; Pedersen OL
    Ugeskr Laeger; 1992 Nov; 154(46):3230-6. PubMed ID: 1462424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin-converting enzyme inhibition and vascular structure in hypertension.
    Gibbons GH
    J Cardiovasc Pharmacol; 1991; 18 Suppl 7():S19-24. PubMed ID: 1725196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin-converting enzyme and angiotensin II receptor subtype 1 inhibitors restitute hypertensive internal anal sphincter in the spontaneously hypertensive rats.
    De Godoy MA; Rattan S
    J Pharmacol Exp Ther; 2006 Aug; 318(2):725-34. PubMed ID: 16648368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regression of hypertension-induced vascular hypertrophy by an ACE inhibitor and calcium antagonist in the spontaneously hypertensive rat.
    Morishita R; Higaki J; Nakamura F; Tomita N; Yu H; Nagano M; Mikami H; Ogihara T
    Blood Press Suppl; 1992; 3():41-7. PubMed ID: 1343288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of antihypertensive treatment on small artery remodeling in hypertension.
    Schiffrin EL
    Can J Physiol Pharmacol; 2003 Feb; 81(2):168-76. PubMed ID: 12710531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular hypertrophy in one-kidney, one clip renal hypertensive rats: a role for angiotensin II?
    O'Sullivan JB; Black MJ; Bertram JF; Bobik A
    J Hypertens; 1994 Oct; 12(10):1163-70. PubMed ID: 7836732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of simvastatin given alone and in combination with valsartan or enalapril on blood pressure and the structure of mesenteric resistance arteries and the basilar artery in the genetically hypertensive rat model.
    Ledingham JM; Laverty R
    Clin Exp Pharmacol Physiol; 2005; 32(1-2):76-85. PubMed ID: 15730439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin-converting enzyme inhibition during development alters calcium regulation in adult hypertensive rats.
    Traub O; Webb RC
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1503-8. PubMed ID: 7505333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in endothelium-derived hyperpolarizing factor in hypertension and ageing: response to chronic treatment with renin-angiotensin system inhibitors.
    Goto K; Fujii K; Kansui Y; Iida M
    Clin Exp Pharmacol Physiol; 2004 Sep; 31(9):650-5. PubMed ID: 15479174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular and cardiac protection by ramipril in spontaneously hypertensive rats: prevention versus regression study.
    Gohlke P; Linz W; Schölkens B; Van Even P; Martorana P; Unger T
    Br J Clin Pract Suppl; 1996 Jul; 84():1-10. PubMed ID: 8994995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pharmacotherapy of arteriosclerosis and its complications. Effect of ACE inhibitors and HMG-CoA-reductase inhibitors].
    Tschudi MR; Noll G; Lüscher TP
    Schweiz Med Wochenschr; 1997 Apr; 127(15):636-49. PubMed ID: 9198890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.